Cargando…
The Histamine H(4) Receptor Participates in the Neuropathic Pain-Relieving Activity of the Histamine H(3) Receptor Antagonist GSK189254
Growing evidence points to the histamine system as a promising target for the management of neuropathic pain. Preclinical studies reported the efficacy of H(3)R antagonists in reducing pain hypersensitivity in models of neuropathic pain through an increase of histamine release within the CNS. Recent...
Autores principales: | Borgonetti, Vittoria, Galeotti, Nicoletta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692811/ https://www.ncbi.nlm.nih.gov/pubmed/36430790 http://dx.doi.org/10.3390/ijms232214314 |
Ejemplares similares
-
Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [(11)C]GSK189254 in anesthetized baboon
por: Logan, Jean, et al.
Publicado: (2012) -
Histamine, histamine receptors, and neuropathic pain relief
por: Obara, Ilona, et al.
Publicado: (2019) -
Central neuronal functions of histamine H(4) receptors
por: Sanna, Maria Domenica, et al.
Publicado: (2017) -
Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis
por: Kim, Kyoung-Woon, et al.
Publicado: (2017) -
Effects of Olopatadine Hydrochloride, a Histamine H(1) Receptor Antagonist, on Histamine-Induced Skin Responses
por: Hashimoto, Takashi, et al.
Publicado: (2010)